Sfoglia per Rivista
Commentary: adjunct antibiotic combination therapy for ulcerative colitis - is it time to investigate Fusobacterium varium?
2014-01-01 Fiorino, G; Danese, S
Commentary: anaemia in inflammatory bowel disease--the most common and ignored extra intestinal manifestation
2014-01-01 Fiorino, G; Allocca, M; Danese, S.
Commentary: antibodies reacting with the infliximab Fab portion - something new?
2013-01-01 Allocca, M; Fiorino, G; Danese, S
Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome
2013-01-01 Jovani, M; Fiorino, G; Danese, S
Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease
2020-01-01 Daude, Sébastien; Remen, Thomas; Chateau, Thomas; Danese, Silvio; Gastin, Isabelle; Baumann, Cédric; Gueant, Jean Louis; Peyrin-Biroulet, Laurent
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: Clinical presentation, treatment and outcome
2016-01-01 Bucci, L.; Garuti, F.; Camelli, V.; Lenzi, B.; Farinati, F.; Giannini, E. G.; Ciccarese, F.; Piscaglia, F.; Rapaccini, G. L.; Di Marco, M.; Caturelli, E.; Zoli, M.; Borzio, F.; Sacco, R.; Maida, M.; Felder, M.; Morisco, F.; Gasbarrini, A.; Gemini, S.; Foschi, F. G.; Missale, G.; Masotto, A.; Affronti, A.; Bernardi, M.; Trevisani, F; Olmi, S; on behalf of Italian Liver Cancer, (ITA. LI. CA) Group.
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients
2019-01-01 Pouillon, L; Danese, S; Hart, A; Fiorino, G; Argollo, M; Selmi, C; Carlo Stella, C; Loeuille, D; Costanzo, A; Lopez, A; Vegni, E; Radice, S; Gilardi, D; Socha, M; Fazio, M; Gonzalez-Lorenzo, M; Bonovas, S; Magro, F; Peyrin-Biroulet, L
Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply
2018-01-01 Goncalves, J; Magro, F; Danese, S; Lakatos, Pl; Ben-Horin, S
Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply
2017-01-01 Bonovas, S; Fiorino, G; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S
Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease
2014-01-01 Cesarini, M; Danese, S
Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply
2018-01-01 Bonovas, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
2020-01-01 Sands, Be; Armuzzi, A; Marshall, Jk; Lindsay, Jo; Sandborn, Wj; Danese, S; Panes, J; Bressler, B; Colombel, Jf; Lawendy, N; Maller, E; Zhang, Hy; Chan, G; Salese, L; Tsilkos, K; Marren, A; Su, Cy
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply
2010-01-01 Szabo, H; Fiorino, G; Danese, S
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
2017-01-01 Petta, S.; Cabibbo, G.; Barbara, M.; Attardo, S.; Bucci, L.; Farinati, F.; Giannini, E. G.; Tovoli, F.; Ciccarese, F.; Rapaccini, G. L.; Di Marco, M.; Caturelli, E.; Zoli, M.; Borzio, F.; Sacco, R.; Virdone, R.; Marra, F.; Felder, M.; Morisco, F.; Benvegnu, L.; Gasbarrini, A.; Svegliati-Baroni, G.; Foschi, F. G.; Olivani, A.; Masotto, A.; Nardone, G.; Colecchia, A.; Persico, M.; Boccaccio, V.; Craxi, A.; Bruno, S.; Trevisani, F.; Camma, C.; Biselli, M.; Caraceni, P.; Cucchetti, A.; Domenicali, M.; Piscaglia, F.; Gramenzi, A.; Granito, A.; Magalotti, D.; Serra, C.; Negrini, G.; Napoli, L.; Salvatore, V.; Benevento, F.; Gazzola, A.; Murer, F.; Pozzan, C.; Vanin, V.; Moscatelli, A.; Pellegatta, G.; Picciotto, A.; Savarino, V.; Delpoggio, P.; Olmi, S.; Dematthaeis, N.; Balsamo, C.; Vavassori, E.; Roselli, P.; Dell'Isola, S.; Ialungo, A. M.; Rastrelli, E.; Rini, F.; Costantino, A.; Affronti, A.; Affronti, M.; Mascari, M.; Mega, A.; Pompili, M.; Rinninella, E.; Mismas, V.; Dall'Aglio, A. C.; Feletti, V.; Lanzi, A.; Cappa, F. M.; Neri, E.; Stefanini, G. F.; Tamberi, S.; Biasini, E.; Missale, G.; Guarino, M.; Ortolani, A.; Chiaramonte, M.; Marchetti, F.; Valerio, M.; Aburas, S.; Inghilesi, A. L.; Cappelli, A.; Golfieri, R.; Mosconi, C.; Renzulli, M.; Coccoli, P.; Zamparelli, M. S.
Increased carotid intima-media thickness in patients with inflammatory bowel disease
2005-01-01 Papa, A; Santoliquido, A; Danese, S; Covino, M; Di Campli, C; Urgesi, R; Grillo, A; Guglielmo, S; Tondi, P; Guidi, L; De Vitis, I; Fedeli, G; Gasbarrini, G; Gasbarrini, A
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
2015-01-01 Sandborn, Wj; Danese, S; D'Haens, G; Moro, L; Jones, R; Bagin, R; Huang, M; Ballard, Ed; Masure, J; Travis, S
Inflammatory bowel disease: estimates from the global burden of disease 2017 study
2020-01-01 Piovani, D; Danese, S; Peyrin-Biroulet, L; Bonovas, S
Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis
2018-01-01 Gragnani, L.; Cerretelli, G.; Lorini, S.; Steidl, Carolina; Giovannelli, A.; Monti, M.; Petraccia, L.; Sadalla, Sinan; Urraro, T.; Caini, P.; Xheka, A.; Simone, Antonella; Arena, U.; Matucci-Cerinic, M.; Vergani, D.; Laffi, G.; Zignego, A. L.
Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply
2020-01-01 Sands, Bruce E; Armuzzi, Alessandro; Marshall, John K; Lindsay, James O; Sandborn, William J; Danese, Silvio; Panés, Julián; Bressler, Brian; Colombel, Jean-Frédéric; Lawendy, Nervin; Maller, Eric; Zhang, Haiying; Chan, Gary; Salese, Leonardo; Tsilkos, Konstantinos; Marren, Amy; Su, Chinyu
Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines
2014-01-01 Gomollon, F; Chowers, Y; Danese, S; Dignass, A; Nielsen, Oh; Lakatos, Pl; Lees, Cw; Lindgren, S; Lukas, M; Mantzaris, Gj; Michetti, P; Moum, B; Peyrin-Biroulet, L; Toruner, M; van der Woude, J; Weiss, G; Stoevelaar, H; Reinisch, W
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Commentary: adjunct antibiotic combination therapy for ulcerative colitis - is it time to investigate Fusobacterium varium? | 1-gen-2014 | Fiorino, G; Danese, S | |
| Commentary: anaemia in inflammatory bowel disease--the most common and ignored extra intestinal manifestation | 1-gen-2014 | Fiorino, G; Allocca, M; Danese, S. | |
| Commentary: antibodies reacting with the infliximab Fab portion - something new? | 1-gen-2013 | Allocca, M; Fiorino, G; Danese, S | |
| Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome | 1-gen-2013 | Jovani, M; Fiorino, G; Danese, S | |
| Comparative accuracy of ferritin, transferrin saturation and soluble transferrin receptor for the diagnosis of iron deficiency in inflammatory bowel disease | 1-gen-2020 | Daude, Sébastien; Remen, Thomas; Chateau, Thomas; Danese, Silvio; Gastin, Isabelle; Baumann, Cédric; Gueant, Jean Louis; Peyrin-Biroulet, Laurent | |
| Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: Clinical presentation, treatment and outcome | 1-gen-2016 | Bucci, L.; Garuti, F.; Camelli, V.; Lenzi, B.; Farinati, F.; Giannini, E. G.; Ciccarese, F.; Piscaglia, F.; Rapaccini, G. L.; Di Marco, M.; Caturelli, E.; Zoli, M.; Borzio, F.; Sacco, R.; Maida, M.; Felder, M.; Morisco, F.; Gasbarrini, A.; Gemini, S.; Foschi, F. G.; Missale, G.; Masotto, A.; Affronti, A.; Bernardi, M.; Trevisani, F; Olmi, S; on behalf of Italian Liver Cancer, (ITA. LI. CA) Group. | |
| Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients | 1-gen-2019 | Pouillon, L; Danese, S; Hart, A; Fiorino, G; Argollo, M; Selmi, C; Carlo Stella, C; Loeuille, D; Costanzo, A; Lopez, A; Vegni, E; Radice, S; Gilardi, D; Socha, M; Fazio, M; Gonzalez-Lorenzo, M; Bonovas, S; Magro, F; Peyrin-Biroulet, L | |
| Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply | 1-gen-2018 | Goncalves, J; Magro, F; Danese, S; Lakatos, Pl; Ben-Horin, S | |
| Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply | 1-gen-2017 | Bonovas, S; Fiorino, G; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S | |
| Editorial: long-term safety and efficacy of certolizumab pegol for Crohn's disease | 1-gen-2014 | Cesarini, M; Danese, S | |
| Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply | 1-gen-2018 | Bonovas, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S | |
| Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open | 1-gen-2020 | Sands, Be; Armuzzi, A; Marshall, Jk; Lindsay, Jo; Sandborn, Wj; Danese, S; Panes, J; Bressler, B; Colombel, Jf; Lawendy, N; Maller, E; Zhang, Hy; Chan, G; Salese, L; Tsilkos, K; Marren, A; Su, Cy | |
| Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply | 1-gen-2010 | Szabo, H; Fiorino, G; Danese, S | |
| Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon | 1-gen-2017 | Petta, S.; Cabibbo, G.; Barbara, M.; Attardo, S.; Bucci, L.; Farinati, F.; Giannini, E. G.; Tovoli, F.; Ciccarese, F.; Rapaccini, G. L.; Di Marco, M.; Caturelli, E.; Zoli, M.; Borzio, F.; Sacco, R.; Virdone, R.; Marra, F.; Felder, M.; Morisco, F.; Benvegnu, L.; Gasbarrini, A.; Svegliati-Baroni, G.; Foschi, F. G.; Olivani, A.; Masotto, A.; Nardone, G.; Colecchia, A.; Persico, M.; Boccaccio, V.; Craxi, A.; Bruno, S.; Trevisani, F.; Camma, C.; Biselli, M.; Caraceni, P.; Cucchetti, A.; Domenicali, M.; Piscaglia, F.; Gramenzi, A.; Granito, A.; Magalotti, D.; Serra, C.; Negrini, G.; Napoli, L.; Salvatore, V.; Benevento, F.; Gazzola, A.; Murer, F.; Pozzan, C.; Vanin, V.; Moscatelli, A.; Pellegatta, G.; Picciotto, A.; Savarino, V.; Delpoggio, P.; Olmi, S.; Dematthaeis, N.; Balsamo, C.; Vavassori, E.; Roselli, P.; Dell'Isola, S.; Ialungo, A. M.; Rastrelli, E.; Rini, F.; Costantino, A.; Affronti, A.; Affronti, M.; Mascari, M.; Mega, A.; Pompili, M.; Rinninella, E.; Mismas, V.; Dall'Aglio, A. C.; Feletti, V.; Lanzi, A.; Cappa, F. M.; Neri, E.; Stefanini, G. F.; Tamberi, S.; Biasini, E.; Missale, G.; Guarino, M.; Ortolani, A.; Chiaramonte, M.; Marchetti, F.; Valerio, M.; Aburas, S.; Inghilesi, A. L.; Cappelli, A.; Golfieri, R.; Mosconi, C.; Renzulli, M.; Coccoli, P.; Zamparelli, M. S. | |
| Increased carotid intima-media thickness in patients with inflammatory bowel disease | 1-gen-2005 | Papa, A; Santoliquido, A; Danese, S; Covino, M; Di Campli, C; Urgesi, R; Grillo, A; Guglielmo, S; Tondi, P; Guidi, L; De Vitis, I; Fedeli, G; Gasbarrini, G; Gasbarrini, A | |
| Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies | 1-gen-2015 | Sandborn, Wj; Danese, S; D'Haens, G; Moro, L; Jones, R; Bagin, R; Huang, M; Ballard, Ed; Masure, J; Travis, S | |
| Inflammatory bowel disease: estimates from the global burden of disease 2017 study | 1-gen-2020 | Piovani, D; Danese, S; Peyrin-Biroulet, L; Bonovas, S | |
| Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis | 1-gen-2018 | Gragnani, L.; Cerretelli, G.; Lorini, S.; Steidl, Carolina; Giovannelli, A.; Monti, M.; Petraccia, L.; Sadalla, Sinan; Urraro, T.; Caini, P.; Xheka, A.; Simone, Antonella; Arena, U.; Matucci-Cerinic, M.; Vergani, D.; Laffi, G.; Zignego, A. L. | |
| Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply | 1-gen-2020 | Sands, Bruce E; Armuzzi, Alessandro; Marshall, John K; Lindsay, James O; Sandborn, William J; Danese, Silvio; Panés, Julián; Bressler, Brian; Colombel, Jean-Frédéric; Lawendy, Nervin; Maller, Eric; Zhang, Haiying; Chan, Gary; Salese, Leonardo; Tsilkos, Konstantinos; Marren, Amy; Su, Chinyu | |
| Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines | 1-gen-2014 | Gomollon, F; Chowers, Y; Danese, S; Dignass, A; Nielsen, Oh; Lakatos, Pl; Lees, Cw; Lindgren, S; Lukas, M; Mantzaris, Gj; Michetti, P; Moum, B; Peyrin-Biroulet, L; Toruner, M; van der Woude, J; Weiss, G; Stoevelaar, H; Reinisch, W |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile